Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
601607 Shanghai Pharmaceuticals Holding
- 17.96
- -0.02-0.11%
Market Closed Apr 30 15:00 CST
66.60BMarket Cap15.34P/E (TTM)
18.08High17.92Low63.66KlotVolume18.00Open17.98Pre Close114.44MTurnover0.23%Turnover Ratio14.63P/E (Static)3.71BShares23.2052wk High0.91P/B50.09BFloat Cap17.2852wk Low19.78Limit Up2.79BShs Float27.89Historical High16.18Limit Down0.89%Amplitude-2.54Historical Low0.49Dividend TTM17.98Avg Price34.94KlotAsk2.73%Div YieldTTM100Lot Size26.71KlotBid
About Shanghai Pharmaceuticals Holding Company
The company is a large pharmaceutical industry group listed in Shanghai and Hong Kong. The company advocates the core corporate values of “innovation, honesty, cooperation, tolerance and responsibility”, and is committed to persevere, improve people's healthy quality of life, and strive to become a leading brand drug manufacturer and health service provider that is respected and has a reputation in the industry. The company's main business is the pharmaceutical industry and pharmaceutical business. The company's main products: hydroxychloroquine sulfate tablets, injectable urastatin, gastric rejuvenation capsules, polysaccharide iron complex capsules, bifidobacteria trifecta active bacterial preparations. Corporate honors: “2023 Asia Pacific Quality Organization - Innovation Award”, the company won 27 national quality awards, 112 provincial and municipal quality awards, the “Fortune 500” list, and won the “Top 50 Global Pharmaceutical Companies”, “Top 25 Global Pharmaceutical Brands”, “China's Top 100 Pharmaceutical Industry Companies”, and “China's Top 100 Pharmaceutical Industry Companies”, and “Best Industrial Enterprise in China's Pharmaceutical R&D Product Line”, ranked 473rd among the 2020 Fortune Global 500, and is one of only two Chinese pharmaceutical companies; In “Fortune It ranked 57th in the 2020 Fortune China 500 published by “Fortune” (Chinese version); ranked 1009th in the 2020 Global Top 2000 Companies published by “Forbes”, and ranked 2nd in the overall strength of China Pharmaceutical Group.
Company Profile
Short Name-A上海医药
Symbol-A601607
Short Name-H上海医药
Symbol-H02607
Company NameShanghai Pharmaceuticals Holding Co.,Ltd.
Listing DateMar 24, 1994
Issue Price4.50
Shares Offered15.00M share(s)
FoundedJan 18, 1994
Listed ExchangeSH Stock Exchange
Legal Representativeqiuhua yang
General Managerbo shen
Secretarytao zhong
Accounting FirmDeloitte Huayong Certified Public Accountants (Special General Partnership)
Securities Representativeyongtaosunshiyi liu
Legal CounselGuo Hao Law Firm (Shanghai)
Employees179
Phone8621-63730908
Office AddressShanghai Pharmaceutical Building, 200 Taicang Road, Shanghai, China
Zip Code200020
Registered AddressNo. 92, Zhangjiang Road, China (Shanghai) Pilot Free Trade Zone
Fax8621-63289333
Emailpharm@sphchina.com
Websitehttp://www.sphchina.com
Business License310000000026221
BusinessPharmaceutical products of various dosage forms (including but not limited to tablets, capsules, aerosols, immunological preparations, granules, ointments, pills, oral solutions, inhalants, injections, liniments, tinctures, suppositories) (including but not limited to the development of chemical raw materials, chemical preparations, Chinese herbal medicines, proprietary Chinese medicines, Chinese herbal medicines, herbal medicines, biological products, narcotic drugs, psychotropic drugs, toxic drugs for medical use [appropriate to the scope of business], vaccines), health products, medical devices and related products Manufacturing and sales, pharmaceutical equipment manufacturing, sales and engineering installation, maintenance, warehousing and logistics, offshore , land and air freight forwarding business, industrial investment, asset management, provision of international economic and trade information and consulting services, leasing of own housing, and import and export business of various kinds of pharmaceuticals and related commodities and technology (the above involves licensed operations).
Company Executives
- Name
- Position
- Salary
- qiuhua yang
- Chairman, Executive Director, Member of the Remuneration and Assessment Committee, Strategy Committee Convener
- --
- wenxue zhang
- Non-executive Directors, Strategy Committee Member
- --
- yongzhong li
- Executive Director, Executive President
- 2.75M
- bo shen
- Executive Director, President, Nomination Committee Members
- 3.05M
- ming dong
- Executive Director
- --
- jun wan
- Independent Directors, Nomination Committee Members
- --
- zhong wang
- Independent Non-Executive Director, Audit Committee Member, Strategy Committee Member, Remuneration and Assessment Committee Convener
- 300.00K
- wenxun huo
- Independent Non-Executive Director, Nomination Committee Convener, Audit Committee Member
- 300.00K
- chaoyang gu
- Independent Non-Executive Director, Nomination Committee Members, Audit Committee Convener, Member of the Remuneration and Assessment Committee
- 300.00K
- tao zhong
- Board Secretary, VP
- 2.04M
- yongtao liu
- Securities Affairs Representative
- --
- shiyi sun
- Securities Affairs Representative
- --
- youli xu
- Chairman of the Supervisory Board, Auditors
- --
- jia ma
- Auditors
- --
- maitiaili mai
- VP
- 182.40K
- yadong zhou
- VP, Chief Financial Officer
- --
- jianyi mao
- VP
- 2.15M
- yong zhao
- VP
- 2.17M
- shuai shao
- VP
- 1.83M
- weidong yu
- Employee Supervisors
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts